Physician observations and perceptions of positive and negative symptoms of schizophrenia: A multinational, cross-sectional survey

被引:18
|
作者
Lecrubier, Yves
Perry, Richard
Milligan, Gary
Leeuwenkamp, Oscar
Morlock, Robert
机构
[1] Hop La Pitie Salpetriere, Unit INSERM 302, F-75013 Paris, France
[2] Adelphi Grp Prod, Bollington, Cheshire, England
[3] NV Organon, Oss, Netherlands
[4] Pfizer Inc, New York, NY USA
关键词
schizophrenia; negative symptoms; positive symptoms; antipsychotics; prescribing practices; survey data;
D O I
10.1016/j.eurpsy.2007.03.003
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose. - To describe physicians' observations and perceptions of patients with schizophrenia and to obtain information about antipsychotic prescribing practices. Methods. - Psychiatrists in the United States and five European countries (France, Germany, Italy, Spain, and the United Kingdom) who prescribed antipsychotics for >= 15 patients with schizophrenia within the preceding 3 months provided data on their patients' demographic and clinical characteristics and their antipsychotic prescribing practices and drug attributes influencing treatment choice. Results. - Data were collected from 872 physicians on 6523 patients (85% European, 15% US). Most patients were aged 25-44 years, 63% were men, and 66% were outpatients. About 50% of patients were moderately to grossly dysfunctional; about 50% were unemployed; 34% and 75% were taking conventional or atypical antipsychotics, respectively. Frequently identified positive symptoms included delusions (73%), disordered thought (59%), and hallucinations (59%); common negative symptoms included social withdrawal (54%), impoverished thought (39%), and blunted affect (38%). Reasons for antipsychotic selection included efficacy for positive (90%) or negative symptoms (62%) and tolerability (47%). Inadequate control was reported more frequently for negative (71-77%) than positive (47-60%) symptoms. Adverse events included sedation, weight gain, and extrapyramidal symptoms. Conclusions. - In this large, multinational, cross-sectional survey, physicians reported that positive symptoms were more common than negative symptoms. Treatment for positive symptoms was more successful than that for negative symptoms, with physicians considering treatment inadequate for > 70% of patients with negative symptoms. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:371 / 379
页数:9
相关论文
共 50 条
  • [1] Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study
    Nordstroem, Anna-Lena
    Talbot, Darren
    Bernasconi, Corrado
    Berardo, Carmen Galani
    Lalonde, Justine
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2017, 63 (02) : 139 - 150
  • [2] Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study
    Fujimaki, Koichiro
    Toki, Shigeru
    Yamashita, Hidehisa
    Oyamada, Takahiro
    Yamawaki, Shigeto
    PSYCHIATRY RESEARCH, 2018, 262 : 600 - 608
  • [3] Predictors Of Negative Symptoms In Chronic Schizophrenia: A Cross-Sectional Study
    Bijali, Shalini
    Singh, Savinder
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S138 - S139
  • [4] Stability of positive and negative symptoms in schizophrenia
    Ribeyre, JM
    Dollfus, S
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1996, 22 : 29 - 31
  • [5] PREDICTORS OF NEGATIVE SYMPTOM DOMAINS IN OUTPATIENTS WITH SCHIZOPHRENIA: A CROSS-SECTIONAL STUDY
    Capatina, Octavia
    Stanculete, Mihaela Fadgyas
    Miclutia, Ioana
    JOURNAL OF EVIDENCE-BASED PSYCHOTHERAPIES, 2021, 21 (02): : 127 - 142
  • [6] Relation of Vitamin D levels with positive and negative symptoms of schizophrenia - A hospital based cross-sectional comparative study
    Ghosh, Soumitra
    Deka, Bikashita
    INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 (09) : 955 - 960
  • [7] Depressive, positive, negative and parkinsonian symptoms in schizophrenia
    Fitzgerald, PB
    Rolfe, TJ
    Brewer, K
    Filia, K
    Collins, J
    Filia, S
    Adams, A
    de Castella, AR
    Davey, P
    Kulkarni, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (03) : 340 - 346
  • [8] Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey
    Emsley, Robin
    Alptekin, Koksal
    Azorin, Jean-Michel
    Canas, Fernando
    Dubois, Vincent
    Gorwood, Philip
    Haddad, Peter M.
    Naber, Dieter
    Manuel Olivares, Jose
    Papageorgiou, Georgios
    Roca, Miguel
    Thomas, Pierre
    Hargarter, Ludger
    Schreiner, Andreas
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2015, 5 (06) : 339 - 350
  • [9] Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study
    Maria Haro, Josep
    Altamura, Carlo
    Corral, Ricardo
    Elkis, Helio
    Evans, Jonathan
    Malla, Ashok
    Krebs, Marie-Odile
    Zink, Mathias
    Bernasconi, Corrado
    Lalonde, Justine
    Nordstroem, Anna-Lena
    SCHIZOPHRENIA RESEARCH, 2015, 169 (1-3) : 234 - 240
  • [10] COVARIANCE OF POSITIVE AND NEGATIVE SYMPTOMS DURING NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA - A REPLICATION
    TANDON, R
    RIBEIRO, SCM
    DEQUARDO, JR
    GOLDMAN, RS
    GOODSON, J
    GREDEN, JF
    BIOLOGICAL PSYCHIATRY, 1993, 34 (07) : 495 - 497